Details of the Drug Reposition

General Information of This Drug (ID: DM8P7FC)

Drug Name
JCARH125   DM8P7FC
Drug Type
CAR T Cell Therapy

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
1 Phase 1/2 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Multiple myeloma DISEWP9B 2A83 Phase 1/2 [1]
------------------------------------------------------------------------------------
4 Clinical trial Indication(s)
Indication Name Indication ID ICD-11 Status REF
Follicular lymphoma DISVEUR6 2A80 Clinical trial [1]
Chronic lymphocytic leukaemia DISEXWC3 2A82.0 Clinical trial [1]
Mantle cell lymphoma DISFREOV 2A85.5 Clinical trial [1]
Non-hodgkin lymphoma DISS2Y8A 2B33.5 Clinical trial [1]
------------------------------------------------------------------------------------

References

1 ClinicalTrials.gov (NCT03436771) Long-term Follow-up Study for Patients Previously Treated With a Juno CAR T-Cell Product